Not even a possibility. That notion was totally debunked and laid to rest with Amazon's statements and confirmation a few weeks ago that it will concentrate on selling medical devices and supplies, and that it has no plans to use its state license to get into the any aspect of the prescription business. There has never been any truth to the hype here that Amazon would have any interest in RAD.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.